XML 108 R79.htm IDEA: XBRL DOCUMENT v3.20.4
Interests in entities - Text Details (Detail)
€ in Millions
 12 Months Ended
Dec. 31, 2020
EUR (€)
Dec. 31, 2019
EUR (€)
Dec. 31, 2018
EUR (€)
Interests in entities [Line Items]      
Number of consolidated subsidiaries not wholly owned 6 6  
Revenue € 19,535 € 19,482 € 18,121
Profit (loss) [1] 1,195 [2],[3] 1,173 [3],[4] € 1,097 [2]
Philips Medical Capital LLC [Member]      
Interests in entities [Line Items]      
Stake in unconsolidated structured entity 26 25  
Associates [member]      
Interests in entities [Line Items]      
Net cash outflow for acquisitions 37    
Subsidiaries with material non-controlling interests [member]      
Interests in entities [Line Items]      
Revenue 468 581  
Profit (loss) € 6 € 9  
Consolidated structured entities [member]      
Interests in entities [Line Items]      
Materiality threshold on group sales, income from operations or net income 5.00%    
[1] For a number of reasons, principally the effects of translation differences and consolidation changes, certain items in the statements of cash flows do not correspond to the differences between the balance sheet amounts for the respective items in the accompanying notes of the consolidated financial statements.
[2] Non-IFRS financial measure. For the definition and reconciliation of the most directly comparable IFRS measure, refer to Reconciliation of non-IFRS information.
[3] Shareholders in this table refers to shareholders of Koninklijke Philips N.V.
[4] Non-IFRS financial measure. For the definition and reconciliation of the most directly comparable IFRS measure, refer to Reconciliation of non-IFRS information.